Gastrointestinal motility and secretion pathways

Gastrointestinal motility and secretion pathways represent a complex network of neuroendocrine and myogenic systems that coordinate the movement of luminal contents and the release of fluids and electrolytes within the digestive tract (Source: StatPearls, 2023). These pathways are primarily regulated by the enteric nervous system (ENS), which utilizes a variety of neurotransmitters and receptors, including serotonin (5-HT), acetylcholine, and dopamine (Source: NIH, 2022). Key molecular components include G protein-coupled receptors (GPCRs) like 5-HT4 and mu-opioid receptors, as well as ion channels and enzymes like guanylate cyclase C (GC-C) (Source: PubMed, 2021). Dysregulation of these pathways leads to functional gastrointestinal disorders such as irritable bowel syndrome (IBS), chronic constipation, and gastroparesis (Source: Mayo Clinic, 2023). Pharmacological intervention targets specific receptors or channels within these pathways to either accelerate transit (prokinetics and secretagogues) or slow it down (antidiarrheals), aiming to restore normal physiological function (Source: Journal of Clinical Medicine, 2020). The coordination of these pathways involves both excitatory and inhibitory signals to smooth muscle, ensuring efficient nutrient absorption and waste elimination. Therapeutic challenges include achieving organ-specific effects without systemic side effects, such as cardiovascular or central nervous system complications.

Other names

GI motility and secretionEnteric nervous system pathwaysGastrointestinal motor and secretory functionsGut motility and secretion

Pharmacological agents modulate these pathways by targeting specific receptors and channels, such as 5-HT4 receptors to stimulate peristalsis, guanylate cyclase C to increase intestinal fluid secretion, and mu-opioid receptors to slow intestinal transit.